Biopharmaceutical companies don’t have to stick to a single bioreactor design during scale-up. That’s according to Stefan Junne, PhD, an associate professor at Aalborg University. Junne, who will be ...
The demand for producing therapeutic recombinant proteins is generating a renewed interest in perfusion cell culture technologies, leading to the development of cell culture media that can support ...
Owing to the rising demand for efficacious biotherapeutics and multiple benefits of single use bioprocessing systems, the biopharmaceutical industry is gradually shifting its focus from conventional ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback